---
schema_version: "secwatch.filing_event.v1"
accession: "0000719135-21-000068"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2021-08-30T23:59:59+00:00"
generated_at: "2026-06-29T07:08:21.845701+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical appoints Wendy Levine to Board of Directors

## Summary
- Wendy Levine appointed as a director effective August 25, 2021, expanding the Board to eight members.
- Levine will serve on the Regulatory Compliance Committee.
- She is Group President and head of advertising at 21GRAMS, part of Real Chemistry, with 25 years of healthcare marketing experience.
- Previous roles include leadership at Johnson & Johnson, Novartis Vaccines, McCann Health, and GSW.
- No arrangement with any other person led to her election; compensation follows standard director program.

## SEC filing metadata
- accession: 0000719135-21-000068
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2021-08-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000071913521000068/0000719135-21-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000071913521000068/a8-kforwendy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000719135-21-000068
- JSON: https://secwatch.observer/filing/0000719135-21-000068.json
- Plain text: https://secwatch.observer/filing/0000719135-21-000068.txt

## Key facts
- Executive change
  Wendy Levine was appointed as Director at Apyx Medical Corp.
  - Action: appointed
  - Role: Director
  source text: On August 24, 2021, the Board of Direct ors (the “Board”) of Apyx Medical Corporation (the “Company”) appointed Wendy Levine to serve as a director of the Company, expanding its Board to eight (8) directors, effective August 25, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913521000068/0000719135-21-000068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.